key: cord-0706133-rhoyeyzm
authors: Huang, Wenhui; Zhao, Zhiwei; He, Zicong; Liu, Shuyi; Wu, Qinxia; Zhang, Xiaoping; Qiu, Xiaoming; Yuan, Huanchu; Yang, Ke; Tang, Xiaomei; Zhang, Shuixing
title: Unfavorable outcomes in pregnant patients with COVID-19 outside Wuhan, China
date: 2020-05-15
journal: J Infect
DOI: 10.1016/j.jinf.2020.05.014
sha: 81e3fb1fc2c1512a05e1e95f2d960da1831e5c5a
doc_id: 706133
cord_uid: rhoyeyzm

nan

Guangzhou, Guangdong 510632, China. Phone: +86 18028656330; E-mail: jdtxm04@126.com

We read with great interest in a recent article by Liu, et al. 1 on the clinical and CT findings of pregnant patients and children with COVID-19. It is clinically oriented, and of great value to the medical workers on the frontline. It revealed that the clinical symptoms of pregnant women were atypical, despite unavailable data about pregnancy outcome in the study. We mainly focused on the pregnancy outcome in patients with COVID-19. It seems that SARS-CoV-2 would be more friendly than its members of the coronavirus family 2 , such as SARS-CoV-1 and MERS-CoV, which caused severe maternal and neonatal complications 3 . Currently, it is too early yet to explicitly determine the effects of SARS-CoV-2 on pregnant women and their fetuses 4 . Here we explored the impact on pregnancy in patients with COVID-19 from multiple medical centers outside Wuhan, China.

We retrospectively analyzed data from 8 pregnant patients who were laboratory-confirmed from January 24 to February 19, 2020. A detailed analysis of clinical features was shown in Table1.

Diagnosis criteria and other details were presented in Supplementary material. The age range was 27-33 years. Two (20%) patients had uterine scarring and one patient was twin pregnancy. Five patients (62.5%) developed mild symptoms; three patients (37.5%) showed severe or critical illness requiring ICU admission, one of which undergone ECMO support; four patients (50%) were performed emergency deliveries because of fetal distress or premature rupture of the membrane (PROM).

Specially, patient 6 with twin pregnancy had preeclampsia with high blood pressure of 180/100mmHg and later developed into eclampsia; patient 7 presented with mild symptoms at first and her condition deteriorated rapidly within 6 hours after admission, with severe complications including septic shock, 3 septic cardiomyopathy, ARDS, MODS, requiring intubation and mechanical ventilation. Six livebirths and one stillbirth were analyzed. Half of the livebirths were premature and admitted to NICU; one twin died at the 18 days of birth with severe pneumonia, referred to "white lung"; another twin showed suspected viral pneumonia on chest CT ( Figure 1 ) and survived after treatment. RT-PCR tests of throat swab specimens for all livebirths were negative.

The cases here highlight three issues that worth stressing. Firstly, unlike previous reports about the favorable outcomes, SARS-CoV-2 might have similar behavior to SARS and MERS, resulting in severe maternal and neonatal outcomes including preterm delivery, PROM, fetal distress, stillborn or neonatal death, admission to ICU or NICU, undergoing endotracheal intubation, septic shock, eclampsia, and MODS. Secondly, those who are older or those who have medical histories such as hypertension and cardiovascular disease tend to fare worse 5 , other than that, immunocompromised status and physiological adaptive changes during pregnancy might contribute to the rapid deterioration into severe or critical illness. Considering the unfavorable outcomes in pregnant patients, any suspected cases during pregnancy should be systematic screening; closely follow-up for mothers and their fetuses after diagnosis should be emphasized. Finally, despite all livebirths were tested negative for SARS-CoV-2, the stillbirth and one neonatal death at 18-days of birth indicated the potential risk of intrauterine infection 6 . There should be more evidence to deep investigation in the future study.

The limitation of our analysis is the absence of data on the amniotic fluid, cord blood, vaginal secretion, and breastmilk samples, as all resources were stretched in a pandemic. Moreover, no data about patients at the first or second trimester was reported, since SARS-CoV-2 infection in different trimester might be associated with different outcomes.

In conclusion, SARS-CoV-2 infection during late pregnancy would have severe maternal and neonatal Cough 

Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Middle East Respiratory Syndrome Coronavirus Infection during pregnancy: A report of 5 cases from Saudi Arabia

Management of pregnant women infected with COVID-19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn

* Shown are the highest intrafebrile temperature. † Reference ranges are as follows: WBC, 3.5×10 9 to 9.5×10 9 /L; NEUT,1.8×10 9 to 6.3×10 9 /L; LY, 1. RT-PCR, Reverse transcription polymerase chain reaction.